Elanco Animal Health Inc (NYSE:ELAN) has a beta value of 1.31 and has seen 9.71 million shares traded in the last trading session. The company, currently valued at $7.53B, closed the last trade at $15.27 per share which meant it lost -$0.21 on the day or -1.36% during that session. The ELAN stock price is -10.54% off its 52-week high price of $16.88 and 48.4% above the 52-week low of $7.88. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.02 million shares traded. The 3-month trading volume is 4.15 million shares.

Elanco Animal Health Inc (NYSE:ELAN) trade information

Sporting -1.36% in the red in last session, the stock has traded in the red over the last five days, when the ELAN stock price touched $15.27 or saw a rise of 3.35%. Year-to-date, Elanco Animal Health Inc shares have moved 2.48%, while the 5-day performance has seen it change -1.99%. Over the past 30 days, the shares of Elanco Animal Health Inc (NYSE:ELAN) have changed -7.17%. Short interest in the company has seen 12.98 million shares shorted with days to cover at 2.92.

Elanco Animal Health Inc (ELAN) estimates and forecasts

Figures show that Elanco Animal Health Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 59.73% over the past 6 months, with this year growth rate of 2.25%, compared to 15.20% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -42.20% and 33.30% for the next quarter. Revenue growth from the last financial year stood is estimated to be 1.80%.

9 analysts offering their estimates for the company have set an average revenue estimate of $1.17 billion for the current quarter. 9 have an estimated revenue figure of $1.15 billion for the next quarter concluding in Jun 2024. Year-ago sales stood $1.26 billion and $1.06 billion respectively for this quarter and the next, and analysts expect sales will shrink by -6.50% for the current quarter and 9.10% for the next.

Earnings growth for 2024 is a modest 3.52% while over the next 5 years, the company’s earnings are expected to increase by 8.87%.

ELAN Dividends

Elanco Animal Health Inc is expected to release its next earnings report between May 07 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Elanco Animal Health Inc (NYSE:ELAN)’s Major holders

Insiders own 0.65% of the company shares, while shares held by institutions stand at 99.20% with a share float percentage of 99.85%. Investors are also buoyed by the number of investors in a company, with Elanco Animal Health Inc having a total of 496 institutions that hold shares in the company. The top two institutional holders are Dodge & Cox Inc with over 84.62 million shares worth more than $851.29 million. As of Jun 29, 2023, Dodge & Cox Inc held 17.18% of shares outstanding.

The other major institutional holder is Primecap Management Company, with the holding of over 49.0 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $492.9 million and represent 9.94% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Dodge & Cox Stock Fund and Vanguard/Primecap Fund. As of Jun 29, 2023, the former fund manager holds about 11.18% shares in the company for having 55.1 million shares of worth $554.31 million while later fund manager owns 17.43 million shares of worth $175.33 million as of Jun 29, 2023, which makes it owner of about 3.54% of company’s outstanding stock.